↓ Skip to main content

The Exceptional Oncogenicity of HTLV-1

Overview of attention for article published in Frontiers in Microbiology, August 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
2 news outlets
twitter
14 X users
facebook
1 Facebook page

Citations

dimensions_citation
65 Dimensions

Readers on

mendeley
79 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Exceptional Oncogenicity of HTLV-1
Published in
Frontiers in Microbiology, August 2017
DOI 10.3389/fmicb.2017.01425
Pubmed ID
Authors

Yutaka Tagaya, Robert C. Gallo

Abstract

Human T-cell leukemia virus-1 (HTLV-1) is the first pathogenic human retrovirus identified in 1979 by the Gallo group. HTLV-1 causes fatal T-cell leukemia (adult T cell leukemia) and a progressive myelopahy (HTLV-1-associated myelopathy/ tropical spastic paraparesis, HAM/TSP) and other disorders. Since the discovery of HTLV-1, several other microorganisms are demonstrated to cause cancer in humans. In this article, we investigated the oncogenic capacity of HTLV-1, in comparison with those of other oncoviruses and one oncobacterium (Helicobacter pylori, H. Pylori) based on published literature. We conclude here that HTLV-1 is one of the most and may be the most carcinogenic among them and arguably one of the most potent of the known human carcinogens. This fact has not been noted before and is particularly important to justify why we need to study HTLV-1 as an important model of human viral oncogenesis.

X Demographics

X Demographics

The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 79 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 79 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 11 14%
Researcher 10 13%
Student > Master 10 13%
Student > Doctoral Student 7 9%
Other 4 5%
Other 11 14%
Unknown 26 33%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 16 20%
Medicine and Dentistry 13 16%
Agricultural and Biological Sciences 9 11%
Immunology and Microbiology 5 6%
Pharmacology, Toxicology and Pharmaceutical Science 2 3%
Other 9 11%
Unknown 25 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 29. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 August 2022.
All research outputs
#1,252,814
of 24,093,053 outputs
Outputs from Frontiers in Microbiology
#721
of 27,122 outputs
Outputs of similar age
#26,005
of 320,823 outputs
Outputs of similar age from Frontiers in Microbiology
#24
of 521 outputs
Altmetric has tracked 24,093,053 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 27,122 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.5. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 320,823 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 521 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.